10 Stocks Moving In Friday's Pre-Market Session

rose 15.60 percent to $6.15 in pre-market trading as the company reported that it has received the FDA approval for Orphan Drug Designation for Frontotemporal dementia treatment.

shares rose 11.80 percent to $16.77 in pre-market trading following Starboard filing showing a 6.8 percent stake in the company.

shares rose 9.99 percent to $19.60 in pre-market trading as the company reported upbeat results for its fourth quarter on Thursday.

shares rose 4.38 percent to $171.00 in pre-market trading after the company announced the U.S. Food and Drug Administration's Gastrointestinal Drugs Advisory Committee voted to recommend Ocaliva.

shares gained 4.06 percent to $202.00 in pre-market trading. S&P Dow Jones Indices announced that Ulta will replace

in the S&P 500.

shares fell 17.27 percent to $4.31 in pre-market trading after the company reported weaker-than-expected results for its third quarter. Ruby Tuesday also announced its Chief Financial Officer Jill Golder will be resigning after three years with the company.

shares fell 10.07 percent to $5.00 in pre-market tradingafter the company reported a worse-than-expected fourth quarter print and announced a CEO change.

shares fell 8.24 percent to $25.40 in pre-market trading after the company reported a 6 percent drop in its same-store sales for March 2016, versus to a 2 percent gain during the same period last year. The company saw net sales for the five-week period ended April 2 fall around 6.5 percent on a year-over-year basis to $1.43 billion.

shares fell 2.57 percent to $89.85 in pre-market trading. Brazil's Bovespa announced a divestment of CME Group position, according to Reuters.

shares fell 1.91 percent to $3.85 in pre-market trading after the company reported preliminary results of tender offer..